Please login to the form below

Not currently logged in
Email:
Password:

European biotech SME award launched

Biotech industry organisation, EuropaBio, is inviting entries for the Most Innovative European Biotech SME Award 2010

Biotech industry organisation, EuropaBio, is inviting entries for the Most Innovative European Biotech SME Award 2010. This new award will acknowledge the contribution made by biotech SMEs to developing a smart, sustainable and inclusive EU economy for 2020 by providing solutions to some of society's biggest future challenges.

The winner will be announced at this year's EuropaBio Biotechnology Benefits for Innovation event on December 9 in Brussels, Belgium and presented with a prize including €10,000.

Dr Andrea Rappagliosi, chairman of EuropaBio, said: "We want to provide a showcase for the very best of the many creative, visionary and innovative European Biotech SMEs and to highlight the vital solutions that they are providing to some of our most pressing societal and environmental needs. This is our way of honouring them and of acknowledging that although they may be small in size, they are great in number and they have enormous potential for providing solutions to help us lead longer, healthier, greener lives for the future."

EuropaBio represents the interests of over 1,800 SMEs, as well as 66 corporate and seven associated members, four bioregions and 22 national biotechnology associations.

Entries close on November 8. To learn more about the award and the prize, download the application form at: http://www.europabio.org

23rd September 2010

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics